APAIIF 亞太人工智能產業總會APAIIFAI Knowledge
AI in Healthcare

Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

September 3, 202610 Views
Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax
醫療AI
Scan.com
醫療影像
AI代理
數字健康

Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

Introduction

On August 31, 2026, medical imaging network company Scan.com announced the closing of $220 million in combined equity and debt financing to expand its medical imaging network and enhance its AI agent infrastructure. Behind this financing lies a startling market reality: in the United States, 85% of medical scan appointments are still made by fax or phone. Scan.com is using AI agent technology to disrupt an industry that has fallen severely behind the times.

Financing Details

Capital Structure

The total $220 million financing consists of two components:

  • Equity: A $90 million Series C round led by Noteus Partners, with participation from Aviva, Concord Health Partners, YZR Capital, and Oxford Capital
  • Debt: $130 million in debt facilities provided by VerisFi Capital and Atempo Growth, earmarked for working capital and M&A activity

Business Scale

Prior to this financing, Scan.com had already achieved significant business growth:

  • Annualized revenue surpassing $165 million, doubling year-over-year
  • Cumulative care provided to over 900,000 patients globally
  • Operations spanning the United States and multiple international markets

Market Pain Points: 85% of Scans Still Booked by Fax

A Fragmented Medical Imaging Market

The U.S. medical imaging market is highly fragmented, with several key problems:

Outdated Booking Processes: 85% of scan appointments are still completed via fax or phone — extremely inefficient, error-prone, and difficult to track.

Lack of Transparency: Patients struggle to access real-time availability, pricing, and subspecialty information across different imaging centers, often passively accepting whatever referral their doctor arranges.

System Silos: Different imaging centers use different EMR systems and scheduling platforms, lacking a unified data interface that makes the referral process cumbersome.

Subspecialty Matching Challenges: Different types of scans require different radiologist subspecialties, but existing systems struggle to automatically match the most appropriate specialist.

Scan.com's Solution

Scan.com provides a unified API that integrates with electronic medical records (EMR) systems and independent imaging centers' scheduling systems, building a national medical imaging infrastructure.

Core AI Agent Applications

Intelligent Routing System

Scan.com's AI agent system plays a critical role in the patient scheduling process:

Real-Time Matching: AI matches patients with the most appropriate imaging center in real time based on referral needs, geographic location, and insurance coverage — considering scanner availability, transparent pricing, and clinical subspecialties.

Dynamic Scheduling: The system continuously monitors appointment availability across imaging centers, automatically optimizing patient distribution to reduce wait times.

Report Routing: Once diagnostic reports are completed, AI automatically routes them to radiologists with the appropriate subspecialty, ensuring the highest quality diagnostic outcomes.

Workflow Automation

AI agents automatically handle scheduling and paperwork, including:

  • Auto-filling referral forms
  • Insurance pre-authorization requests
  • Patient reminders and confirmations
  • Pre-scan preparation instructions

Human-in-the-Loop Model

Despite extensive automation, Scan.com maintains a team of care guides to ensure administrative tasks are handled by AI while human clinical touchpoints are preserved. This "human-in-the-loop" model is especially important in healthcare settings, where patients often need human support when facing medical procedures.

U.S. Market Expansion Plans

Scan.com entered the U.S. market in 2023, and U.S. business now accounts for the majority of its total operations. The new funding will primarily be used for:

Expanding the National Provider Network: Establishing partner imaging centers in more states to improve nationwide coverage.

Technology Infrastructure Upgrades: Strengthening AI agent systems to improve the accuracy and speed of appointment matching.

M&A Integration: Rapidly expanding market share and technological capabilities through strategic acquisitions.

Lessons for the Asia-Pacific Region

Scan.com's business model holds important reference value for the medical imaging market across Asia-Pacific:

Similar Market Pain Points: Many Asia-Pacific countries have equally outdated medical imaging scheduling systems with severe fragmentation, creating enormous application space for AI agent technology.

Digital Transformation Opportunity: As healthcare digitalization accelerates across Asia-Pacific, AI medical imaging platforms similar to Scan.com could replicate this success in markets such as Japan, South Korea, Australia, and Singapore.

Investment Signal: Scan.com's successful financing provides an important market validation signal for healthcare AI startups across Asia-Pacific.

Industry Impact and Competitive Landscape

Scan.com's rise is driving digital transformation across the entire medical imaging industry. Traditional imaging centers and hospital systems face pressure to accelerate digital upgrades to remain competitive.

Meanwhile, other healthcare AI companies are actively positioning themselves in related areas: Rad AI focuses on radiology report automation, Aidoc provides AI-assisted diagnostics, and Nuance (under Microsoft) continues to deepen its work in medical voice recognition and document automation.

Conclusion

Scan.com's $220 million financing is not only a strong endorsement of its business model, but also an important confirmation of AI agent technology's potential in healthcare. In a market where 85% of appointments are still made by fax, the scope for AI agent intervention is enormous. As Scan.com accelerates its national expansion, the digital transformation of the U.S. medical imaging market will enter a fast lane — a trend that will also provide an important development blueprint for the global healthcare AI market.

FAQ

Related Articles

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era
AI in Healthcare

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era

Aidoc's AI radiology platform covers nearly 2,000 hospitals processing 60 million annual cases, receiving FDA clearance in January 2026 for a foundation model CT triage solution covering 14 clinical conditions. Radiology AI accounts for 76% of all FDA AI medical device clearances as the industry enters a new era of scaled deployment.

Nov 2, 202612
AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months
AI in Healthcare

AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months

Multiple large-scale 2026 clinical studies confirm AI ambient scribe benefits: 2.3 million encounter data shows physician burnout dropping from 51.9% to 38.8% (31% reduction), 13-16 minutes saved per shift, 87-89% semantic accuracy, and 2x+ ROI within 14 months, though research notes time savings are often reinvested into patient interaction rather than reduced work hours.

Nov 1, 202614
Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial
AI in Healthcare

Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial

Stanford's SIMCO AI framework, simulating 218 million immune cells, discovered that the aspirin-lansoprazole (SALPZ) combination is 15× more effective than aspirin alone at preventing preterm birth, with a median 17.3-day labor delay and 87.3% responder rate. FDA has authorized a 670-patient clinical trial.

Oct 31, 202611